In this episode, we'll cover new company launches, collaborations, advancements in the clinical pipeline, and important regulatory updates during March 1-15, 2025. Tune in to catch all the latest developments in global antibody therapeutics development.

In this episode, we'll cover new company launches, collaborations, advancements in the clinical pipeline, and important regulatory updates during February 15 - March 1, 2025. Tune in to catch all the latest developments in global antibody therapeutics development.

In this episode, we'll cover new company launches, collaborations, advancements in the clinical pipeline, and important regulatory updates during February 1 - 15, 2025. Tune in to catch all the latest developments in global antibody therapeutics development.

In this episode, we'll cover new company launches, collaborations, advancements in the clinical pipeline, and important regulatory updates during January 15 - February 1, 2025. Tune in to catch all the latest developments in global antibody therapeutics development.

In this episode, we'll cover new company launches, collaborations, advancements in the clinical pipeline, and important regulatory updates during January 1 - 15, 2025. Tune in to catch all the latest developments in global antibody therapeutics development.

In this episode, we'll cover new company launches, collaborations, advancements in the clinical pipeline, and important regulatory updates during December 15 - 31, 2024. Tune in to catch all the latest developments in global antibody therapeutics development.

In this episode, we'll cover new company launches, collaborations, advancements in the clinical pipeline, and important regulatory updates during December 1 - 15, 2024. Tune in to catch all the latest developments in global antibody therapeutics development.

In this episode, we'll cover new company launches, collaborations, advancements in the clinical pipeline, and important regulatory updates during November 15 - December 1, 2024. Tune in to catch all the latest developments in global antibody therapeutics development.